Nightingale awarded “Health Innovation” of the year

Nightingale’s technology has been recognized as “Health Innovation” of the year by the Health Awards 2018. The Health Awards & Foresight Forum is an annual event focusing on the future vision of Finnish healthcare. We will be allocating the €5,000 prize towards our planned science magazine for children, equipping the next generation of budding innovators with a passion for medicine, science and technology.

"We believe our technology will provide better tools for the prevention of chronic diseases in primary care. Solving the prevailing issues in healthcare today requires the development of cutting-edge innovations and the courage to take advantage of the possibilities they bring. We are honored to receive this award and industry support, as we continue to make strides towards bringing our service to healthcare systems globally,” said Teemu Suna, CEO and Founder, Nightingale Health.

The Health Awards & Foresight Forum is a recognized annual competition and event carried out by Tamro Corporation and partners in the Finnish health industry. The Health Awards & Foresight Forum brings together contributors, decision makers, companies and innovators in the healthcare and wellbeing sector. 

Nightingale’s service currently provides health data from biomarker analysis to leading academic research institutions and plans to assist clinicians in the near future to provide more personalized guidance to patients. In the long-term, we plan to fully integrate our service into healthcare systems and provide tools for patients to follow-up their own health – enabling preventative healthcare for chronic diseases (e.g. diabetes and cardiovascular disease). In March 2017, Nightingale was selected as one of the winners of MIT’s (Massachusetts's Institute of Technology) Solve competition, hosted at the United Nations HQ. In November 2017, Nightingale was awarded as one of the most innovative biotech SMEs in Europe at the European Parliament.

Stay in the know

Our latest health headlines delivered to your inbox.